Physician
Urology
Dr. J E. Pontes, MD
|
|
Give Review
Pontes is an expert in the field of Urology. Pontes is a published doctor and has 83 publications published. The lastest was: 'Should Gleason score 7 prostate cancer be considered a unique grade category?'
Publications
- Fellowship training as a modifier of the surgical learning curve.
- Variations among experienced surgeons in Cancer control after open radical prostatectomy.
- Surgeon experience is strongly associated with biochemical recurrence after radical Prostatectomy for all preoperative risk categories.
- Malignant undifferentiated sex cord-stromal testis tumor with brain metastasis: case report.
- The surgical learning curve for prostate Cancer control after radical prostatectomy.
- CT-guided percutaneous cryotherapy of Renal masses.
- Lycopene and soy isoflavones in the treatment of prostate Cancer.
- High frequency of allelic losses in high-grade prostate Cancer is associated with biochemical progression after radical prostatectomy.
- Contemporary impact of transrectal ultrasound lesions for prostate Cancer detection.
- Management of clinical T1 Bladder transitional cell carcinoma by radical cystectomy.
- Salvage radiation for a rising PSA following radical Prostatectomy.
- Radical Prostatectomy nomograms in black American men: accuracy and applicability.
- Incidence and significance of positive urine cultures in patients with an orthotopic neoBladder.
- Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate Cancer.
- Prostate Cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
- Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate Cancer: a multivariable analysis.
- Conservative surgery for Renal cell carcinoma: a single-center experience with 100 patients. 1989.
- Structural alteration of p53 protein in patients with muscle invasive Bladder transitional cell carcinoma.
- How accurately does Prostate biopsy Gleason score predict pathologic findings and disease free survival?
- Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the Bladder: prognostic significance and comparative analysis in primary and metastatic tumors.
- Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical Prostatectomy.
- Salvage radical Prostatectomy.
- Advancing perspectives on prostate Cancer: multihormonal influences in pathogenesis.
- Grading the invasive component of urothelial carcinoma of the Bladder and its relationship with progression-free survival.
- Impact of location and multifocality of positive surgical margins on disease-free survival following radical Prostatectomy: a comparison between African-American and w...
- Patients with abnormal ultrasound of the Prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors.
- Prostate Cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
- Should the age specific Prostate specific antigen cutoff for Prostate biopsy be higher for black than for white men older than 50 years?
- Significance of the Gleason scoring system after neoadjuvant hormonal therapy.
- The impact of race on biochemical disease-free survival in early-stage prostate Cancer patients treated with surgery or radiation therapy.
- Prostatic paraganglioma: 5-year followup.
- Origin and racial distribution of glandular tissue in the anterior compartment of the Prostate: an autopsy study.
- Urinary diversion-related outcome in patients with pelvic recurrence after radical cystectomy for Bladder cancer.
- Role of radical prostatectomy in patients with prostate Cancer of high Gleason score.
- Outcome of palliative Urinary diversion in the treatment of advanced malignancies.
- Lymph node size does not correlate with the presence of prostate Cancer metastasis.
- Should Gleason score 7 prostate Cancer be considered a unique grade category?
- Population-based study of pelvic lymph node positivity in clinically localized prostate Cancer: a study comparing African Americans and whites.
- Responsiveness of human Prostate carcinoma bone tumors to interleukin-2 therapy in a mouse xenograft tumor model.
- Racial differences and prognostic significance of tumor location in radical Prostatectomy specimens.
- Treatment outcome after radical Prostatectomy is not adversely affected by a pre-existing penile prosthesis.
- Matrix metalloproteinase-9 expression in Bladder washes from Bladder cancer patients predicts pathological stage and grade.
- Quality of life in patients undergoing salvage procedures for locally recurrent prostate Cancer.
- The influence of race on the efficacy of curative radiation therapy for carcinoma of the Prostate.
- Limited role of radionuclide bone scintigraphy in patients with Prostate specific antigen elevations after radical Prostatectomy.
- Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate Cancer.
- Primary adenocarcinoma of the urethra with metastasis to the glans penis: successful treatment with chemotherapy and radiation therapy.
- Management of primary urethral Cancer.
- Salvage surgery or salvage radiotherapy for locally recurrent prostate Cancer.
- Systemic interleukin 2 therapy for human Prostate tumors in a nude mouse model.
- Focal xanthogranulomatous pyelonephritis presenting as a Renal tumor with vena caval thrombus.
- Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate Cancer.
- High flow malignant priapism with isolated metastasis to the corpora cavernosa.
- Prognostic implications of a positive apical margin in radical Prostatectomy specimens.
- Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) Renal cell carcinoma.
- Incidence of urethral involvement in female Bladder cancer: an anatomic pathologic study.
- Orthotopic urinary diversion is a viable option in patients undergoing salvage cystoprostatectomy for recurrent prostate Cancer after definitive radiation therapy.
- Inhibition of mUrine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interl...
- Interleukin-13 receptors on human Prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exo...
- Diagnostic and prognostic markers for human prostate Cancer.
- The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate Cancer: a multivariate analysis of positive surgical mar...
- The mechanism of local tumor irradiation combined with interleukin 2 therapy in mUrine renal carcinoma: histological evaluation of pulmonary metastases.
- High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive Bladder cancer.
- A comparison of the W-stapled ileal reservoir with hand-sewn reservoirs for orthotopic Bladder replacement.
- Local tumor irradiation augments the response to IL-2 therapy in a mUrine renal adenocarcinoma.
- Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate Cancer.
- Effect of local tumor irradiation and interleukin-2 therapy in different mUrine tumors.
- Radiation-induced effects on mUrine kidney tumor cells: role in the interaction of local irradiation and immunotherapy.
- Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a mUrine renal cell carcinoma model.
- Intralesional treatment of established mUrine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases.
- Surgical excision of duodenal/pancreatic metastatic Renal cell carcinoma.
- Polymorphisms of the matrix metalloproteinases associated with prostate Cancer.
- E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate Cancer.
- Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate Cancer.
- Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate Cancer.
- Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate Cancer.
- Phase III study of interferon alfa-NL as adjuvant treatment for resectable Renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
- Prognostic impact of the 2009 UICC/AJCC TNM staging system for Renal cell carcinoma with venous extension.
- [Main grade of Gleason''s 7 score of the surgical sample correlated with biologic progression in patients treated for total Prostatectomy].
- Radical prostatectomy with Bladder neck preservation: impact of a positive margin.
- Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined Cancer is largely related to inadequate surgica...
- Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate Cancer.
Procedures Preformed
- Cystectomy
- Cystometry
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Education
-
Federal University of Ceara Faculty of Medicine
Hospital
-
DMC - Detroit Receiving Hospital -
DMC Harper University Hospital
Drug Facts
| NPI NUMBER | 1285681981 | |
| NPPES Provider LastName | PONTES | |
| NPPES Provider FirstName | J | |
| NPPES Provider ZIPCode | 482012013 | |
| NPPES Provider State | MI | |
| Specialty Description | Urology | |
| Total Claim Count | 127.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285681981 |
| Last Name Of The Provider | PONTES |
| First Name Of The Provider | J |
| View All |
Similar Doctors
|
|
Dr. Ramarao Kaza, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Fumo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ranko Miocinovic, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Riad Farah, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Craig G. Rogers, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Abd-El-Rahman M. Abd-El-Barr, MD |
|
|
Dr. Nazia Q. Bandukwala, DO |
|
|
Dr. Michael J. Ehlert, MD |
|
|
Dr. Casey Leong, MD |